Investment in the health and pharmaceutical industry slumped in China in 2019 after highly active mergers and acquisitions (M&A) activities in the previous few years. There were 15 outbound investment deals conducted by financial buyers in the pharmaceutical sector from mainland China in 2019, falling from 31 deals in the previous year.
Number of outbound investment deals in the pharmaceutical sector from mainland China between 2016 and 2019, by funding method
The deal volume figures refer to the number of deals announced, regardless of whether or not a value is disclosed for the deal.
Outbound deals refer to mainland China company acquisitions abroad.
Financial buyer refers to investors that acquire companies with the objective of realizing a return on their investment by selling the business as a profit at a future date and mainly, but not entirely, comprise private equity (PE) and venture capital (VC) funds.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
PwC. (April 15, 2020). Number of outbound investment deals in the pharmaceutical sector from mainland China between 2016 and 2019, by funding method [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1112659/china-pharmaceutical-outbound-investment-deals-by-funding-method/
PwC. "Number of outbound investment deals in the pharmaceutical sector from mainland China between 2016 and 2019, by funding method." Chart. April 15, 2020. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1112659/china-pharmaceutical-outbound-investment-deals-by-funding-method/
PwC. (2020). Number of outbound investment deals in the pharmaceutical sector from mainland China between 2016 and 2019, by funding method. Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1112659/china-pharmaceutical-outbound-investment-deals-by-funding-method/
PwC. "Number of Outbound Investment Deals in The Pharmaceutical Sector from Mainland China between 2016 and 2019, by Funding Method." Statista, Statista Inc., 15 Apr 2020, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1112659/china-pharmaceutical-outbound-investment-deals-by-funding-method/
PwC, Number of outbound investment deals in the pharmaceutical sector from mainland China between 2016 and 2019, by funding method Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1112659/china-pharmaceutical-outbound-investment-deals-by-funding-method/ (last visited November 10, 2024)
Number of outbound investment deals in the pharmaceutical sector from mainland China between 2016 and 2019, by funding method [Graph], PwC, April 15, 2020. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1112659/china-pharmaceutical-outbound-investment-deals-by-funding-method/
